Independent experts say OncoMed cancer drug unlikely to succeed in study

(Reuters) - Independent investigators have informed OncoMed Pharmaceuticals Inc that its pancreatic cancer drug is unlikely to meet the main goal in a mid-stage study, the company said on Monday.

http://ift.tt/1KzzFxU

from Reuters: Health News
via animenewspro